Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Doug Bean who wrote (1582)	1/9/2000 8:36:00 PM
From: Richaaard	Respond to of 1837

I second that trend. If we hit mid $9, then I think price will approach $12 within a few days. From there it'll be up to the company and available news. If we don't get any substantive press release, the $12 area will be short lived.

To: Doug Bean who wrote (1582)	1/9/2000 11:17:00 PM
From: vestor	Read Replies (1) \| Respond to of 1837

Given the number of patents coming off in 2000 the generic drug makers may have their best year in a long time. See the Warburg report. Given the demographics and recent performance of the drug/medical sector there are some saying a rotation from High Tech to Life Sciences is about due.